Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market buy 10% owner bought 400,000 shares at an average $5.75 ($2,298,600)
  4. 4 Open-market buy 10% owner bought 300,000 shares at $5.96 ($1,788,180)
  5. 4 Exercise or conversion Chief Operating Officer acquired 8,500 shares (option exercise)
  6. 4 Open-market buy 10% owner bought 500,000 shares at an average $4.50 ($2,247,600)
  7. 4 Open-market buy 10% owner bought 454,399 shares at an average $3.89 ($1,767,484)
  8. 4 Open-market buy SVP, CFO and Secretary bought 40,000 shares at $2.47 ($98,800)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Shares withheld for taxes Sr VP, Research & CSO gave up 1,666 shares (to pay taxes)
  18. 4 Exercise or conversion President and CEO acquired 53,265 shares (option exercise)
  19. 4 Exercise or conversion SVP, CFO and Secretary acquired 8,316 shares (option exercise)
  20. 4 Exercise or conversion Chief Operating Officer acquired 500 shares (option exercise)

Page 8 of 25 · 484 filings